The Robert T. Malison Yale-Chulalongkorn Stress, Alcohol Use and Psychopathology Training Program
罗伯特·T·马利森耶鲁-朱拉隆功压力、酒精使用和精神病理学培训计划
基本信息
- 批准号:10665205
- 负责人:
- 金额:$ 24.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-04-01 至 2028-02-29
- 项目状态:未结题
- 来源:
- 关键词:AddressAffectAlcohol consumptionAlcoholsChronicClinicalClinical TrialsCollaborationsCommunitiesDedicationsDeveloping CountriesDevelopmentDiseaseDrug AddictionEconomicsEnvironmentFacultyFellowshipGeneticGenetic studyGoalsHealthHealth ProfessionalHospitalsIncomeInfrastructureInstitutionInterdisciplinary StudyInternationalLeadMedical Care CostsMedicineMental disordersMolecular BiologyNamesPolicy ResearchPopulationPostdoctoral FellowPreventionPsychiatryPsychopathologyPsychopharmacologyPublic HealthRecording of previous eventsResearchResearch PersonnelResearch TrainingScientistSiteStressSubstance Use DisorderThailandTrainingTraining ProgramsTranslational ResearchUniversitiesclinical translationcommunity based participatory researchdesigneconomic disparityexperienceimplementation researchmedical schoolsmultidisciplinaryneuroimagingpre-doctoralpreventprogramssocialstress related disorder
项目摘要
Abstract
Psychiatric disorders are a set of chronic, non-communicable diseases (NCDs), a global public health problem
of enormous economic, social, and medical cost to the international community. Stress, alcohol use and other
factors (social and environmental; physical disorders) often exacerbate psychiatric disorders. Low and middle
income and developing countries are disproportionately affected due to both economic disadvantages and the
less well-established institutional infrastructures dedicated to the understanding, treatment and prevention of
psychopathology. We propose a collaborative research training program in the multidisciplinary, translational
research of stress, alcohol use and psychopathology between Faculty of Medicine, Chulalongkorn University in
Bangkok, Thailand (the lead Thai site) Phramongkutklao (PMK) Hospital, also in Bangkok, and Prince of Songkla
University (PSU) in Hat Yai, Thailand; and the Yale University School of Medicine in the U.S. The project is
directed by leaders in Thailand and the US, Dr. Kalayasiri at Chulalongkorn, and Drs. Potenza and Gelernter at
Yale, mPIs for this application. Three major training mechanisms are proposed for Thai trainees, including long-
term (1-2-yr) predoctoral and postdoctoral fellowships, and short-term (1-6 month) fellowships. During the five-
year program, training responsibility increases at Chulalongkorn, PMK, and PSU (as experience builds) and
decreases at Yale. This program builds on an extensive research program in Psychiatry at Yale University School
of Medicine, and on existing training and research collaborations between investigators at Yale and investigators
at Chulalongkorn in the study of the genetics and clinical correlates of psychopathology (especially substance
use disorders) in Thai populations. The program will contribute to the capacity of investigators at Chulalongkorn,
PMK and PSU and more generally in Thailand to conduct state-of-the-art research in interdisciplinary and
translational research in psychiatry through a range of training experiences (genetics, molecular biology, clinical,
developmental, psychopharmacology, clinical trials, neuroimaging, implementation, community, and policy
research); and has strong ongoing potential for clinical translation. The explicit long-term goal of the program will
be to build a critical mass of scientists, health professionals, and academics with expertise and a sustainable
research environment at the collaborating Thai institutions to better understand, treat, and prevent the NCDs of
psychiatric illnesses. This training program is also specifically designed to serve a major public health purpose
by enhancing Thailand’s capacity to confront major health concerns including alcohol and other stress-related
disorders that are unprecedented in Thailand’s history. The context of this program is a long-term research and
training collaboration between Yale and Chulalongkorn that focused on drug dependence which was co-led by
at Yale by Drs. Gelernter and Malison. This new program with a new focus is expanded in scope to address the
needs of Thailand better and include a Thai mPI, and is now named “The Robert T. Malison Yale-Chulalongkorn
Stress, Alcohol Use and Psychopathology Training Program” for Dr. Malison, who passed in July, 2020.
抽象的
精神疾病是一组慢性,非通信疾病(NCD),这是一个全球公共卫生问题
国际社会的巨大经济,社会和医疗费用。压力,饮酒和其他
因素(社会和环境;身体疾病)常常加剧精神疾病。低和中间
收入和发展中国家由于经济缺陷而受到不成比例的影响
不太公认的机构基础设施致力于理解,治疗和预防
心理病理学。我们提出了一个多学科,翻译的协作研究培训计划
研究压力,饮酒和心理病理学的研究
泰国曼谷(泰国领先地点)也在曼谷的Phramongkutklao(PMK)医院和桑克拉亲王
泰国Hat Yai的大学(PSU);美国耶鲁大学医学院该项目是
由泰国和美国的领导人执导,在Chulalongkorn的Kalayasiri博士和博士。 Potenza和Gelernter
耶鲁大学,此应用程序的MPI。提出了针对泰国训练的三种主要培训机制,包括长期
学期(1-2岁)前和博士后奖学金以及短期(1-6个月)奖学金。在五个期间
年度计划,Chulalongkorn,PMK和PSU的培训责任(随着体验的建设)和
耶鲁大学下降。该计划以耶鲁大学学校的精神病学广泛研究计划为基础
耶鲁大学调查人员与研究人员之间的现有培训和研究合作
在Chulalongkorn的遗传学和临床相关性研究中
在泰国人群中使用疾病)。该计划将有助于调查员在丘拉隆科恩(Chulalongkorn)的能力,
PMK和PSU以及泰国更普遍地在跨学科和
通过一系列培训经验(遗传学,分子生物学,临床,,
发育,心理药理学,临床试验,神经影像学,实施,社区和政策
研究);并具有持续的临床翻译潜力。该计划的明确长期目标将
建立具有专业知识的科学家,卫生专业人员和学者的批判性和可持续性
合作的泰国机构的研究环境,以更好地理解,治疗和防止
精神病。该培训计划还专门设计用于实现主要公共卫生目的
通过增强泰国面对重大健康问题在内的能力,包括酒精和其他与压力有关
泰国历史上史无前例的疾病。该计划的背景是一项长期研究,
耶鲁大学和Chulalongkorn之间的培训合作,重点是毒品依赖
在耶鲁大学博士。 Gelernter和Malison。这个具有新焦点的新程序在范围中扩展了
泰国的需求更好,包括泰国MPI,现在被命名为“罗伯特·马利森·耶鲁·杜拉隆龙龙”
Malison博士于2020年7月通过了压力,饮酒和心理病理学培训计划”。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOEL GELERNTER其他文献
JOEL GELERNTER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOEL GELERNTER', 18)}}的其他基金
Genetics of Alcohol Dependence in African Americans: Recruitment
非裔美国人酒精依赖的遗传学:招募
- 批准号:
10474310 - 财政年份:2018
- 资助金额:
$ 24.69万 - 项目类别:
Genetics of Alcohol Dependence in African Americans: Recruitment
非裔美国人酒精依赖的遗传学:招募
- 批准号:
9769607 - 财政年份:2018
- 资助金额:
$ 24.69万 - 项目类别:
Identifying Methamphetamine Risk Variants by Extreme Phenotype Exome Sequencing
通过极端表型外显子组测序识别甲基苯丙胺风险变异体
- 批准号:
9086352 - 财政年份:2015
- 资助金额:
$ 24.69万 - 项目类别:
Identifying Methamphetamine Risk Variants by Extreme Phenotype Exome Sequencing
通过极端表型外显子组测序识别甲基苯丙胺风险变异体
- 批准号:
9280890 - 财政年份:2015
- 资助金额:
$ 24.69万 - 项目类别:
Identifying Methamphetamine Risk Variants by Extreme Phenotype Exome Sequencing
通过极端表型外显子组测序识别甲基苯丙胺风险变异体
- 批准号:
9920116 - 财政年份:2015
- 资助金额:
$ 24.69万 - 项目类别:
Methamphetamine and Other Substance Use Disorder Genetics in Thailand
泰国的甲基苯丙胺和其他药物使用障碍遗传学
- 批准号:
10585560 - 财政年份:2015
- 资助金额:
$ 24.69万 - 项目类别:
Identifying Methamphetamine Risk Variants by Extreme Phenotype Exome Sequencing
通过极端表型外显子组测序识别甲基苯丙胺风险变异体
- 批准号:
9456704 - 财政年份:2015
- 资助金额:
$ 24.69万 - 项目类别:
相似国自然基金
饮酒刺激肝细胞分泌外泌体对股骨头内H型血管的影响及分子机制
- 批准号:82272508
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
伏隔核多巴胺信号通过调节D1R-、D2R-MSNs活动影响个体差异饮酒行为的机制研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
性激素受体相关的性别差异与饮酒因素影响胃癌发生发展的机制研究
- 批准号:82172894
- 批准年份:2021
- 资助金额:55.00 万元
- 项目类别:面上项目
性激素受体相关的性别差异与饮酒因素影响胃癌发生发展的机制研究
- 批准号:
- 批准年份:2021
- 资助金额:54.7 万元
- 项目类别:面上项目
伏隔核多巴胺信号通过调节D1R-、D2R-MSNs活动影响个体差异饮酒行为的机制研究
- 批准号:82101569
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
相似海外基金
Developing and Evaluating a Positive Valence Treatment for Alcohol Use Disorder with Anxiety or Depression
开发和评估治疗伴有焦虑或抑郁的酒精使用障碍的正价疗法
- 批准号:
10596013 - 财政年份:2023
- 资助金额:
$ 24.69万 - 项目类别:
Identifying the Effects of Race-Related Stressors on Laboratory- Induced Stress and Craving among African Americans with Alcohol Use Disorder
确定种族相关压力源对患有酒精使用障碍的非裔美国人实验室诱发的压力和渴望的影响
- 批准号:
10664454 - 财政年份:2023
- 资助金额:
$ 24.69万 - 项目类别:
Proud to Quit (P2Q): A Person-centered mobile technology intervention for smoking cessation among transgender adults
自豪地戒烟(P2Q):以人为本的移动技术干预跨性别成年人戒烟
- 批准号:
10647479 - 财政年份:2023
- 资助金额:
$ 24.69万 - 项目类别:
A Mobile App to Address Co-Occurring Sleep Problems and Heavy Alcohol Use among Veterans Outside of Care Settings
一款解决退伍军人在护理机构之外同时发生的睡眠问题和酗酒问题的移动应用程序
- 批准号:
10647530 - 财政年份:2023
- 资助金额:
$ 24.69万 - 项目类别:
Elucidating causal mechanisms of ethanol-induced analgesia in BXD recombinant inbred mouse lines
阐明 BXD 重组近交系小鼠乙醇诱导镇痛的因果机制
- 批准号:
10825737 - 财政年份:2023
- 资助金额:
$ 24.69万 - 项目类别: